Abstract
Background An improved understanding of oral human herpesvirus-8 (HHV-8) viral dynamics could provide insights into transmission risk and guide vaccine development.
Methods We evaluated HHV-8 oral shedding dynamics in Ugandan adults stratified by Kaposi sarcoma (KS) and HIV status. Participants were followed for ≥4 weeks, with daily home oral swab collection to quantify HHV-8 using Polymerase Chain Reaction. Shedding rates were defined by the number of days with HHV-8 detected divided by the total days with swabs and compared by group using hurdle models.
Results 295 participants were enrolled; median age was 35 years (range 18-71), 134 (45%) were male. HHV-8 was detected more frequently among participants with KS (HIV+/KS+ 56/76, 74%; HIV-/KS+ 9/18, 50%) than those without KS (HIV+/KS-36/125, 29%; HIV-/KS-16/76, 21%); odds of shedding did not differ significantly by HIV status. Among participants with HHV-8 detected, shedding rates did not differ significantly by group. Median per-participant viral loads among positive samples were lowest in HIV+/KS+ (3.1 log10 copies/mL) and HIV-/KS+ participants (3.3 log10 copies/mL) relative to HIV+/KS-(3.8 log10 copies/mL) and HIV-/KS-participants (4.0 log10 copies/mL). All groups had participants with low-viral load intermittent shedding and those with high-viral load persistent shedding. Within each group, individual HHV-8 shedding rate positively correlated with median HHV-8 log10 copies/mL, and episode duration positively correlated with peak viral load.
Conclusions Oral HHV-8 shedding is highly heterogeneous across Ugandan adults with and without KS and HIV. Persistent shedding is associated with higher median viral loads regardless of HIV and KS status.
Competing Interest Statement
Potential conflicts of interest: JTS receives consulting fees from Pfizer for advising on SARS-CoV-2 therapeutics and Glaxo Smith Kline for advising on HSV vaccines. CC receives fees for consulting from Recordati Rare Disease, for sitting on the Scientific Advisory Board of Viracta Therapeutics, and receives research funding from ImmunityBio and Janssen. All other authors report no potential conflict of interest.
Funding Statement
Funding: This work was supported by the National Cancer Institute at the National Institutes of Health [R01 CA239593 to WP, JTS, JO; K23 CA150931 to WP; U54 CA190146 to CC; P30 CA015704 to CC] and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health [P30 AI027757 to CC].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Makerere University Research and Ethics Committee of Makerere University, the Fred Hutch Cancer Center Institutional Review Board of Fred Hutchinson Cancer Center, and the University of Washington Institutional Review Board of the University of Washington gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
